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ABSTRACT 
 This review discusses the convergence of several research and engineering fields 
working to design and integrate electrochemical biosensing units into contact lenses. Tear 
fluid contains a wide variety of biochemical information about both ocular and systemic 
environments. By measuring biomarkers and their concentrations, it is possible to 
determine whether certain disease states are present. Emerging biosensor technology, most 
notably materials constructed at the nano scale, are showing incredible precision in the 
identification and quantification of individual molecules. Miniature, integrated biosensing 
units, which require energy self-sufficiency and wireless operation, consist of a few 
fundamental electronic components. The major systems discussed in this work include: 
energy, circuits and communication. Publicly documented contact lens prototypes provide 
an idea of how far the field has come and what challenges lie ahead. The projected clinical 
impact of real-time, continuous tear fluid monitoring is immense. It is vital that the eye 
care field remains keenly aware of the efforts underway and active in the conversation 
going forward.  
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INTRODUCTION 
 In 1967, the first biosensor was created for the purpose of measuring glucose levels in 
liquid samples.1,2 It contained the immobilized enzyme glucose oxidase on the surface of an 
oxygen electrode, which broke glucose into electrons and inert byproducts.2 The electrode 
measured electron flow and the supporting sensor unit calculated concentration proportional to 
the current produced.2 Two years later, in 1969, the Apollo Guidance Computer safely landed the 
Apollo 11 spacecraft on the moon. The revolutionary command module controlled the ship’s 
trajectory and velocity as several dozen computers in Houston tracked and communicated with it 
from Earth. Today, the average smartphone has more computing power than all of the Apollo 
spacecraft combined.3 Developments in technology over the last several decades have not only 
revolutionized the way we interact with the world, but are changing the way we understand and 
interact with our own biology.  
 Contact lenses have historically been used for the correction of refractive error. 
Approximately 125 million individuals worldwide, more than 30 million of them Americans, 
wear contact lenses.4,5 Researchers and engineers from diverse fields are working to embed 
contact lenses with electronic systems. Using biosensors to measure the contents of tear fluid has 
become one of the more intriguing applications. One approach uses materials embedded with 
optically active polymers to indicate the presence of certain molecules.6 The other method and 
subject of this work uses integrated electrochemical sensors in lenses to measure the 
biochemistry of tear fluid. The final goal being the identification and quantification of tear 
contents for the purpose of diagnosis and management of disease.  
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 This work is intended to provide the health care community with a physiological and 
technological foundation for understanding the developments being made in the field of 
electrochemical contact lens biosensors.  
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DIAGNOSTIC POTENTIAL OF TEAR FLUID 
 Blood has historically been the principal diagnostic fluid used to examine health and 
disease. It is responsible for transporting nutrients and waste to and from all of the major tissues 
in the body. Collecting blood is relatively invasive and in the case of individuals with diabetes, 
must be done multiple times each day.7 Tear fluid has been examined as a potential diagnostic 
fluid for several decades. Advances in diagnostic technology, aided by new sample preparation 
techniques, have revealed more biological information and complexity in tear fluid than was 
previously suspected.  
 Tear fluid is produced by a number of tissue types in the ocular environment and serves 
many important functions including: protection, lubrication, nutrition source and refractive 
surface.8 The three distinguishable layers are lipid (outermost), aqueous (central layer) and 
mucin (associated with corneal epithelium). The lipid layer is primarily responsible for providing 
a smooth, airtight barrier that slows the evaporation of aqueous fluid.9 The aqueous layer carries 
the bulk of nutrition and enzymatic protection and is made of water (98% by volume), proteins, 
electrolytes and other small molecules.10 The mucin layer creates a junction and physical barrier 
to protect corneal epithelial cells.11  
 
Tear Production 
 The main and accessory lacrimal glands, meibomian glands and conjunctival goblet cells 
make the majority of tear fluid.12 Some contents diffuse into tear fluid through the cornea and 
conjunctiva vessels, as well as after cellular damage.12 Meibomian glands in the upper and lower 
tarsal plates of the lids produce a majority of the lipid layer.13 The long, tubular glands are 
- 4 - 
apocrine in nature, meaning that portions of their apical epithelial cells are pinched off and 
rupture into the gland lumen.9 Meibomian secretion occurs passively as the eyelids are closed 
and the glands are squeezed by the tarsal plates.9 There is evidence that a percentage of lipids in 
tear fluid may come from the conjunctiva, cornea and lacrimal glands.14 Mucins come in two 
forms: major gel-forming and membrane-associated. Major gel-forming mucins are produced by 
goblet cells of conjunctiva, while membrane-associated mucins are expressed by lacrimal gland, 
corneal and conjunctival epithelial cells.11 
 The main and accessory lacrimal glands produce the majority of aqueous tear fluid.13 The 
main lacrimal gland is innervated primarily by parasympathetic fibers and is responsible for 
reflex, basal and emotional tearing.9,13 Reflex tearing is stimulated when the conjunctiva or 
cornea is irritated by chemical, thermal, mechanical or light stimuli.9 The main and accessory 
glands provide the majority of basal tearing, but as much as 25% of basal tear fluid comes from 
the conjunctiva.15 The conjunctiva is constantly secreting or absorbing water and ions to 
maintain optimum physiological conditions.15  
 There have been a number of studies showing a large range in measured basal tear 
volume, but 5-10μL is an accepted value for healthy individuals.9 Basal tear secretion rate is 
measured at roughly 1.2μL/minute or 1.2mL/day, while reflex tearing can increase the rate by 
50-100 times.9,15 When the eyes are closed reflex tearing and turnover rates decrease, while 
serum protein leakage increases.12 Tear turnover rate is estimated at 16-40% per minute.9,17 The 
majority of fluid is drained into the upper and lower puncta, evaporated or absorbed back into the 
cornea and conjunctiva.9 Normal evaporation is estimated at 0.1μL/min, but can jump to 
1.7μL/min with a deficient lipid layer.15 Normal tear thickness has been measured to be roughly 
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3μm using laser interferometry and measurements taken over time can be used to calculate tear 
evaporation rates.16 
 
Tear Measurement 
 Tear fluid has historically been difficult to collect and measure because of its small 
volume. Several collection techniques have been used, including: capillary tubes, Schirmer 
strips, liquid eye flushing and absorbent materials.12 Literature shows that the collection 
technique used and the type of tearing measured have a large influence on the concentration and 
even presence of certain molecules.15 For example, glucose concentration is highest when reflex 
tears are collected after the conjunctiva has been mechanically irritated.15 Glucose concentration 
is lowest when non-stimulated basal tear are collected.15 Capillary tubes are proving to be a 
reliable and minimally contaminating collection method. Many feel that they should be the 
standard for future studies.12  
 Several molecular analysis techniques have been used to measure the presence or 
concentration of target molecules. These include polyacrylamide gel electrophoresis, high 
performance liquid chromatography, mass spectrometry, PCR, immunoblotting and ELISA.8,18,19 
These methods are often enhanced by additional sample preparation techniques that aim to 
improve sensitivity and selectivity.19 New generation mass spectrometers combined with liquid 
crystal techniques are greatly enhanced precision.8 Most of the tests commercially available are 
restrictive to clinical practice due to cost, speed, sample size, and/or false positive/negative 
reliability.20  
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Biochemical Composition 
 Tear fluid contains of unique mixture biomolecules, each serving a number of functions. 
Published research shows that there is great effort underway toward compiling a comprehensive 
catalog of tear contents and the relation to blood chemistry.  
 
Table 1: Comparison of the concentration of biochemical components in tears and blood.55 
 
Proteins 
 Roughly 500 proteins have been identified in tear fluid, most of them being synthesized 
in the ocular environment.18 There are four proteins, all excreted by the lacrimal glands, that 
makeup the vast majority of total protein concentration: lysozyme, lactoferrin, lipocalin and 
sIgA.9 Lysozyme alone, having strong gram-positive bacteriolytic properties, is 30-40% of total 
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proteins.21 Lactoferrin prevents hydroxyl radicals and makes iron unavailable for bacterial 
growth.9,21 Lipocalin is known for having lipid-binding properties and also sequesters iron from 
bacteria.9 sIgA is part of the body’s defense from HSV, EBV, HIV, adenovirus, Streptococcus 
epidermidis and Chlamydia trachomatis.13  
 The significant proteins that leach through conjunctival capillaries include albumin 
(osmotic pressure), IgG (blood-born immunity) and transferrin (iron transport).21 The lacrimal 
gland has been shown to secrete several important proteins including: IgM (higher in allergic 
conjunctivitis), IgE, serotonin, epidermal growth factor, angiotensin, macrophage inflammatory 
protein and lacritin.13 Several antimicrobial peptides are expressed from corneal and conjunctival 
epithelial cells to protect the ocular environment from foreign organisms.19 The total protein 
concentration in tear fluid is 6-11mg/mL, compared to 60-80mg/mL for blood.12,22 It is thought 
that the production of protein fluctuates with water production in order to keep concentrations 
steady.9 
 
Electrolytes and Metabolites 
 Electrolytes in tear fluid include sodium, potassium, calcium, magnesium, chloride, 
phosphate and bicarbonate.13 Metabolites include amino acids, urea, ascorbate, glucose, and 
lactate. Around 90 metabolites have been classified and their concentrations can reveal the 
physiological condition of ocular surface cells.12 Ascorbate, which comes from the corneas and 
lacrimal glands, is very important in controlling superoxide radicals on the ocular surface.24 Free 
radicals come from cellular metabolism and photochemical reactions.24  
 Using glucose as an example, a concomitant correlation has been measured between tear 
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and blood glucose levels.7 Carbohydrate loads, ingested orally, show increased tear glucose 
concentration with about a 10-minute delay behind blood glucose levels.23 Tear glucose levels 
alone have been shown to determine whether a subject is diabetic.7 Non-diabetic subjects have 
tear glucose concentrations ranging from 0 to 65mg/dL, while subjects with diabetes mellitus on 
average have higher levels, reaching 84mg/dL.15  
 
Lipids and Mucins 
 The lipid layer is made of wax esters, cholesterols, phospholipids, triglycerides, free fatty 
acids, polar lipids, and neutral diesters.12 Over 150 unique lipids have been identified, most of 
which come from the meibomian glands. Wax esters and cholesterol esters are responsible for 
creating the air resistant top layer of tear film.9 The mucin layer is made of several types of 
glycoproteins, which are either secreted into the aqueous or associated with cell membranes.13 
Most mucins are made of more than 50% carbohydrates.9  
 
Other molecules 
 Several systemic drugs have been identified in tear fluid including: phenobarbital, 
carbamazepine, methotrexate, acetaminophen, ampicillin, rifampicin and cytosine arabinose.9 
Their pathways into tear fluid are not fully understood, but lipid soluble drugs are often 
measured at concentrations similar to serum levels.9 
 
Disease States 
 Biomarkers in tear fluid have been linked to several ocular conditions including 
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evaporative keratoconjuntivitis sicca, meibomian gland disease, Sjogren syndrome, blepharitis, 
androgen deficiency and lacrimal gland dysfunction.8 It is suggested that the balance between 
oxidative reactions in tear fluid plays a key role in maintaining ocular health.18 Oxidative stress, 
which can be measured by the presence of several enzymes and byproducts, has been linked to 
cataracts, AMD and glaucoma.24 Superoxide dismutase, one of the major systemic antioxidant 
enzymes, was found in tear fluid.24 Lipid peroxidation can also be observed through the marker 
malondialdehyde (MDA).24  
 Dry eye is known to cause increased inflammation and osmolarity in tear fluid. The 
concentration of certain meibomian lipids changes significantly in individuals with dry eye.8 Dry 
eyes have lower concentrations of carnitine, an important molecule for fatty acid transport.12 
Several immune mediators have been linked to dry eye disease. Higher IL-Ra and IL-8 levels are 
strongly correlated with corneal inflammation and epithelial defect staining.25 Some biomarkers 
have been identified that might be used to indicate the extent of ocular rosacea.8 Free fatty acids, 
cholesterol and wax ester levels are greatly altered in blepharitis.12  
 Analysis of cytokine and chemokine levels can discriminate between different allergic 
pathologies.12 Conditions such as vernal keratoconjuntivitis and atopic keratoconjuntivitis show 
increased levels of IgE, an antibody that signals mast cells to release histamine.12 VKC shows up 
to 130 times higher Eosinophil Cationic Protein (ECP) concentrations, while MMP-1 and MMP-
9 greatly increase as well.12 Keratoconus displays elevated levels of IL-6, TNF-a, MMP-1 and 
MMP-9.12 The ratio of lysozyme to IgA increases in thyroid eye disease.8 
 In non-proliferative diabetic retinopathy, T-cell Stimulating Protein A (TSPA) decreases, 
while lysozyme and apolipoprotein AI increase.8,26 In proliferative diabetic retinopathy, nerve 
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growth factor (NGF), zinc a2-glycoprotein and lactoferrin increase.19,26 Lacryglobin, which is 
associated with cancer of the colon, breasts, prostate, lungs and ovaries, has been found in tear 
samples.8 Researchers state that it is possible to identify breast cancer by evaluating tear proteins 
alone.12,19  
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INTEGRATED BIOSENSOR UNITS  
 An electrochemical biosensor is defined as a compact analytical unit incorporating a 
biologically derived recognition component associated with an electrochemical transducer.2 The 
components at the heart of contact lens biosensors can be put into 4 categories: biosensing 
elements, power circuits, communication circuits, and supporting components. 
 Biosensing, or recognition, components are often biomolecules that mimic parts of living 
systems.20,27 They typically include receptors, enzymes, antibodies, nucleic acids and other 
biologically active proteins.2,28 Receptors, for example, are embedded into electrically 
conductive materials whose electrical properties change when target molecules bind.27,29 A 
transducer is used to convert the output current into a signal that is interpreted by an external 
computation device.30 Biosensing in a simple, homogeneous fluid is relatively easy. When a 
sensor is placed in a complex solution, such as blood or tear fluid, false receptor binding and 
saturation of recognition components can significantly skew measured values.31   
 
Figure 1: Recognition components of a biosensor.27 
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Emerging Sensor Materials 
 A revolution in biosensing has been fueled by research and development in the field of 
nanotechnology. Nanotechnology generally refers to processes or materials that are controllable 
below the scale of 100 nanometers.32 The average human hair is around 60,000-80,000 
nanometers wide33. Using bottom up or atom-by-atom construction techniques allows engineers 
to design sensor materials with optimum specificity and sensitivity in mind.20,34 Some of the 
other benefits include increased surface-to-volume ratio, lower energy consumption and lower 
long-term costs.34  
 Graphene and its derivatives, carbon nanotubes and nanowires, are the main areas of 
research being explored for advanced biosensor materials. Graphene is a two-dimensional sheet 
of carbon atoms bonded together in a hexagonal pattern.35 Carbon nanotubes are graphene sheets 
rolled into tube form, while carbon nanowires are solid rods of carbon molecules.35 Carbon in 
these forms becomes extremely conductive and energy efficient.35 Enzymes and antibodies can 
be embedded into carbon nanomaterial to form incredibly dense biosensor recognition 
elements.36 Embedding nanomaterials with DNA, cells, and organelles is also being 
explored.36,37 The ‘doped’ materials act as electrical gates, altering the sensor circuit when target 
molecules are bound.27,32 Even though nanomaterials have different electrical properties when 
compared to conventional materials, signal transduction can be measured in nearly the same 
way.27,29 Because of the immensely small size of nanotubes and nanowires, an almost endless 
combination of detection elements can be integrated into single sensor units.20 Carbon nanotube 
films have been demonstrated on soft plastics, showing that flexible soft contact lens applications 
are possible in the future.32 
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Providing Energy 
 Current micro sensor units do not require large amounts of energy to operate, due to their 
small size and periodic operation.38 Even so, one of the biggest challenges facing engineers in 
the field of contact lens electronics is energy self-sufficiency while the device is being worn.  
 The transmission and communication of data consumes a majority of the power in micro-
sensor units.39 In the last 15 years, battery technology has tripled in energy density and many 
research groups have demonstrated flexible lithium ion platforms.40,41 Batteries will likely only 
be needed in early generations of biosensing lenses.41,42 The power provided is inherently linked 
to volume and size requirements of contact lenses do not allow significant energy densities.42  
 
Energy Harvesting 
 Energy harvesting at the micro scale has supplemented or replaced batteries in many 
small devices. The human body and surrounding environment are sources of relatively large 
amounts of energy, which can be collected and converted into electrical current.39 For example, 
heat from the wrist has been used to power watches.41 Nanomaterials are being used to further 
optimize and reduce the size of micro harvesting systems even further.41 The micro harvesting 
methods being explored include thermal, kinetic, biofuel, solar, and electromagnetic.41 It is 
important to keep in mind that current micro harvesting technology doesn’t produce the peak 
currents needed for wireless communication, meaning that early contact lens units might rely on 
batteries or super-capacitors to operate independently throughout the day.41 Super-capacitors, 
- 14 - 
which are solid-state devices, have been proposed as an alternative to batteries for energy 
storage.42 
 
Thermal 
 Micro-scale thermal harvesters or thermocouples can convert small amounts of thermal 
energy into electricity.43 Thermal harvesters are solid-state units that use temperature differences 
between two unique metals to generate electrical flow.44 Electrons are naturally propelled from 
hot to cold and the current produced is proportional to temperature difference, known as the 
Seebeck coefficient.44 Thermocouples can be linked in series or parallel to increase power 
output.45  
 The front of the eye has an average temperature of 32–34°C (~90-93°F) when open and is 
constantly emitting thermal energy to the environment.46 A temperature difference of 1.5K 
(2.7°F) has been shown to produce 300mV, which is enough to power early contact lens 
prototypes.43,46 Some thermocouples have been demonstrated as small as 100μm.43  
 Thermal energy has also been used to power individual wireless nodes of 
electroencephalograms (EEG).44 The units produce and use power up to a few milliwatts, which 
is enough to power an electrode and processing unit.44 
 
Kinetic 
 As the eye moves throughout the day, there kinetic energy that can be converted into 
electrical current using piezoelectric technology.39 Piezoelectric transducers, getting their name 
from the Greek word for “pressure”, use special capacitors that deform easily under mechanical 
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stress.41 The stress creates a flow of electrons and electrical current is produced.41 Some units 
have been demonstrated down to 1mm in size.41 Nanowires are being researched as piezoelectric 
transducers, which promise to reduce size and increase efficiency even further.38  
 
Biofuel 
 Biofuel is readily available in the tear film in the form of glucose and ascorbate.47,48 One 
example of a micro biofuel cell uses glucose oxidase, similar to the glucose sensors previously 
discussed, to generate electrons from the breakdown of glucose.47 The current and voltage 
produced increase with larger concentrations of glucose.47 Early examples of glucose harvester 
use living enzymes which breakdown over time, but have been shown to produce power for up to 
one month.38 Glucose can also be abiotically catalyzed with noble metals and activated carbon to 
reduce enzyme breakdown.45 Ascorbate is also being explored as a source of biofuel. Early work 
shows that it can be abiotically oxidized and produce enough power for early prototype glucose-
sensing contact lenses.48 
 
Solar 
 Solar cells, also known as photovoltaic cells, create electricity by converting captured 
photons into electrons. State-of-the-art micro-scale photovoltaic harvesters show almost the same 
power density as full-scale cells.41 Outdoor illumination provides more energy than any other 
micro-harvesting sources, while typical indoor lighting provides 10-100uW/cm2. 41 For context, 
90uW is enough to power a wireless pulse oxymeter sensor.41  
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 Solar harvesting efficiency is being improved by artificially reproducing the fundamental 
steps in photosynthesis. One early example is based on the light-harvesting biomolecules found 
in phototropic bacteria.45 Infrared radiation is also being used to power implanted cardiac 
pacemakers.45 The devices can be powered for 24 hours after 17 minutes of exposure.45  
 
Electromagnetic 
 Electromagnetic radiation is all around the modern world in the form of 
telecommunication devices. Radio frequency waves, also known as RF, can be harvested from 
the environment and converted into electrical current.49 While ambient RF energy is quite 
constant, the density of waves is relatively low and not likely useable for small devices with 
small antennas.41 By using dedicated RF sources, harvesting units have been reliably powered at 
a distance of a few meters.49 An example unit sends waves at 906MHz with a power of 2-3 
watts.41 A chip in a harvesting unit converts the waves into 15mW of energy at 30cm, with 
power decreasing significantly as distance increases.41 
 Some implantable devices use near-field inductive coupling for both power transfer and 
communication.49 Studies show that short (5 second) exposures to RF do not significantly heat 
biological tissue, demonstrating that the technology could eventually replace batteries in 
biomedical applications.49  
 
Hybrid 
 Power and efficiency can be increased dramatically by combining multiple harvester 
methodologies.39 Hybrid examples under investigation include piezoelectric/biofuel and 
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piezoelectric/solar cells.38,39 Not all harvesting sources produce the same kind (AC vs. DC) and 
amount of current. Thermoelectric, solar and biofuel cells produce DC current, while 
piezoelectric and RF cells produce AC current.41 Power management circuits are required to 
convert and store energy, while providing steady output for sensing and communication 
components.39,41 These chips have been demonstrated to the millimeter scale.42 
 
Figures 2: Schematic integrated sensor with solar cell.56 
  
Figures 2 and 3: Integrated sensor with solar cell.56 
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Wireless Communication and Integrated Circuits 
 Wireless micro sensor units currently use radio frequency technology to communicate 
with external devices.46 The ocular environment is not covered by thick tissue, so radio 
communication is relatively unhindered.46 integrated sensor units have dedicated communication 
chips to convert electrical current output from sensors into radio waves.46 The waves sent from 
the chips deviate from a standard frequency, for example 900MHz, in proportion to current from 
the sensors.46 An external receiver analyzes the frequency spectrum and converts the data into 
concentration values.46 These communication chips have been constructed and operated on the 
scale of a few millimeters.46  
 The use of nanomaterials is also being explored to reduce the size and energy 
consumption of communication chips.50 Proposed units will continue to use electromagnetic 
radiation to transmit data, but utilize different frequency bands.50  
 An integrated circuit at the heart of the biosensor unit is required to facilitate information 
movement between the sensor and communication components. Fully integrated chips have been 
demonstrated as small as 0.6 mm × 0.6 mm, with a thickness of 200 μm.46  Large advances in 
circuit technology are producing circuit hardware with the elasticity of rubber bands.51 
Transparent, flexible electronic circuits are currently being used in many biomedical 
applications.52 Carbon nanotubes are being investigated as circuit and transistor materials, 
promising not only smaller size but also immensely faster electron transfer and computation 
speed.50 
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Public Prototypes 
 There are several academic research groups whose prototyping work is leading to 
integrated electrochemical contact lenses biosensors. One group in Japan has constructed a 
biosensor using the glucose oxidase on the surface of a polydimethylsiloxane (PDMS) contact 
lens.23 Although it does not yet operate wirelessly, it has been used to measure tear glucose in-
situ on a rabbit eye.23  
 The most advanced example comes from a group at the University of Washington. They 
integrated a wireless glucose sensor unit onto a rigid contact lens platform. The device consists 
of two differential glucose sensor modules, a sensor read-out circuit, an antenna, a 
telecommunication circuit, and imbedded interconnects. It has shown linear output in glucose 
concentrations of 0–2 mM, which covers the normal tear range of 0.1–0.6 mM.46 The 
telecommunication circuit receives wireless power from and transmits data to a dedicated 
external RF unit at a distance of several centimeters.46 This technology is currently being 
developed further by Google and Novartis.57 The physical parameters of modern contact lens 
materials are being investigated to determine their compatibility with integrated sensor units.53  
 
Figures 4: Glucose sensing contact lens prototype designed by Google.57 
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Figures 5: Schematic glucose sensing contact lens prototype designed by Google.57  
 
 
 
 
 
 
 
 
 
 
 
 
 
- 21 - 
DISCUSSION 
 There are many challenges that lie ahead for the emerging field of electrochemical 
contact lens biosensors. One of the biggest tasks will be compiling and normalizing tear fluid 
data. Future studies should compare the tear compositions of a large number of healthy and 
unhealthy individuals, as well as differences based on age and gender. For example, the aging 
lacrimal gland is known to undergo fibrosis, resulting in a change in the quantity and 
composition of fluid excreted.9 Studies should adopt universal tear sampling techniques to ensure 
data is reliable and repeatable. One confounding factor that might prove the above tear data 
compilation to be difficult is the complex and open nature of the ocular environment. Unlike 
blood, which is in a closed system, tear fluid is potentially contaminated by whatever 
environment the eye is exposed to. This can be overcome, but immense precision and calibration 
will be required. 
 It will also be important to continue studying how contact lens wear affects the 
biochemistry in the ocular environment. Mechanical irritation during initial contact lens wear is 
known to affect basal tear rates and solute concentrations, but values stabilize after periods of 
adaptation.15 Some studies have also shown that contact lens wear increases tear evaporation.25 
Biocompatibility is another important topic that needs to be explored. Many researchers have 
been examining the effects of electrical circuits being in close proximity to biological tissue.54 
 While research and development into fields like nanotechnology are certainly advancing 
biosensing and microelectronics, progress will likely come in incremental steps. Early examples 
of contact lens sensors will be relatively rudimentary in the information they provide. Glucose 
measurement will likely be the first application to reach the clinic. Other early units might 
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monitor the osmolarity or oxidation balance in the ocular environment. Technology is certainly 
the limiting factor and open collaboration between researchers and engineers is critical for the 
field to flourish. As large corporations begin to develop and commercialize these technologies, 
market potential and return on investment might be the main driving forces going forward. 
 Tear fluid is a rich and complex substance that contains a wealth of information about 
both ocular and systemic environments. As understanding of tear physiology expands and 
technology becomes less of a limiting factor, the conversation going forward should be enhanced 
by clinicians who fit and prescribe contact lenses. They are uniquely able to understand and 
interact with the individuals behind the lenses.  
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